Oliver Luxxe Assets’s Select Medical SEM Stock Holding History

Oliver Luxxe Assets’s Portfolio SEM Stock Details SEM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-24,521	Closed	-$478K	–	214
2021 Q3	$478K	Buy	24,521 +3,669	+18%	+$72.8K	0.13%	133
2021 Q2	$475K	Buy	20,852 +3,550	+21%	+$73.7K	0.13%	132
2021 Q1	$318K	Buy	+17,302	New	+$284K	0.1%	152

Other funds holding SEM

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Oliver Luxxe Assets's SEM Position: Q4 2021 in Review

Oliver Luxxe Assets sold out of Select Medical (SEM) in Q4 2021, closing a stake of 24,521 shares — an estimated $478K sold.

Oliver Luxxe Assets first reported a position in SEM in Q1 2021 and held it in 3 quarters. The position peaked at $478K in Q3 2021. 244 funds tracked by Wall St. Rank hold SEM as of Q4 2021.

Oliver Luxxe Assets reported no remaining Select Medical position as of Q4 2021 after selling out during the quarter.
Oliver Luxxe Assets sold 24,521 Select Medical shares in Q4 2021, an estimated $478K.
Oliver Luxxe Assets first reported a position in Select Medical in Q1 2021 and held it in 3 quarters.
Oliver Luxxe Assets's Select Medical position peaked at $478K in Q3 2021.
244 funds tracked by Wall St. Rank held Select Medical as of Q4 2021.

Based on Oliver Luxxe Assets's 13F filing for Q4 2021, filed 4 Feb 2022.